3-69959370-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001354604.2(MITF):c.1129C>T(p.Arg377Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R377R) has been classified as Likely benign.
Frequency
Consequence
NM_001354604.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MITF | NM_001354604.2 | c.1129C>T | p.Arg377Ter | stop_gained | 9/10 | ENST00000352241.9 | |
MITF | NM_000248.4 | c.808C>T | p.Arg270Ter | stop_gained | 8/9 | ENST00000394351.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MITF | ENST00000352241.9 | c.1129C>T | p.Arg377Ter | stop_gained | 9/10 | 1 | NM_001354604.2 | P4 | |
MITF | ENST00000394351.9 | c.808C>T | p.Arg270Ter | stop_gained | 8/9 | 1 | NM_000248.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 31, 2023 | Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 150 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34142234, 27759048) - |
Waardenburg syndrome type 2A Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Testing Center for Deafness, Department of Otolaryngology Head & Neck Surgery, Institute of Otolaryngology, Chinese PLA General Hospital | Jan 01, 2019 | - - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 12, 2016 | The p.Arg371X variant in MITF has been identified by our laboratory in one indiv idual with hearing loss, which is assumed to have occurred de novo. It has not been reported in large population studies. This nonsense variant leads to a pr emature termination codon at position 371 and is located 51 nucleotides from the end of the penultimate (second to last) exon. Therefore, this variant is expect ed to undergo nonsense mediated mRNA decay (NMD) (Holbrook 2004) resulting in a n absent protein. However, due to its close location to the penultimate intron it could escape NMD and leading to a truncated protein. Heterozygous loss of fu nction variants in the MITF gene are well described in individuals with Waardenb urg syndrome. In summary, the p.Arg371X variant meets the criteria to be classi fied as pathogenic for hearing loss in an autosomal dominant manner. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at